- Home
- NAMS vs OPCH Comparison
NAMS vs OPCH Comparison
Compare NAMS & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAMS | OPCH |
|---|---|---|
| Founded | 2019 | N/A |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.5B |
| IPO Year | 2022 | 1996 |
Fundamental Metrics
Financial Performance| Metric | NAMS | OPCH |
|---|---|---|
| Price | $25.28 | $24.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 7 |
| Target Price | ★ $46.75 | $36.57 |
| AVG Volume (30 Days) | 1.0M | ★ 1.7M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.81 | 3.25 |
| EPS | N/A | ★ 0.29 |
| Revenue | $22,503,000.00 | ★ $4,998,202,000.00 |
| Revenue This Year | $17.96 | $7.21 |
| Revenue Next Year | $540.65 | $8.55 |
| P/E Ratio | ★ N/A | $83.90 |
| Revenue Growth | N/A | ★ 16.17 |
| 52 Week Low | $23.05 | $18.01 |
| 52 Week High | $42.21 | $36.80 |
Technical Indicators
Market Signals| Indicator | NAMS | OPCH |
|---|---|---|
| Relative Strength Index (RSI) | 38.58 | 61.74 |
| Support Level | N/A | $22.97 |
| Resistance Level | $28.87 | $24.83 |
| Average True Range (ATR) | 0.98 | 0.54 |
| MACD | -0.04 | -0.03 |
| Stochastic Oscillator | 25.00 | 92.52 |
Price Performance
Historical ComparisonAbout NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.
About OPCH Option Care Health Inc.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.